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Tuberculosis (TB) remains a leading cause of death from infectious disease worldwide with 80,000 pe-
diatric deaths annually. Disease caused by Mycobacterium tuberculosis (Mtb) is usually asymptomatic in
pediatric patients and resolves after completion of standard therapy with isoniazid (INH). Rare reports
document children greater than 10 years of age in endemic regions developing adult type cavitary
disease, an infectious pulmonary tuberculosis lesion. This is a notable case of post-infectious pulmonary
TB disease with adult type cavitation in an immigrant adolescent, which developed even after
completing standard therapy with INH. With increasing immigration of refugees from endemic regions
into the United States, the Center for Disease Control implemented standardized testing and treatment of
TB. However even with identiﬁcation of disease, many immigrants may not seek treatment or complete
therapy given lack of health insurance, and poor access to health care. This case of a 14 year old
adolescent with post primary cavitary TB highlights the importance of directly observed therapy (DOT)
and medication compliance. Perhaps as noteworthy, this case also emphasizes the need for pediatricians
to recognize the impact on public health and the potential for spread of active TB within schools and the
community especially in pulmonary cavitary lesion.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tuberculosis (TB) remains a leading cause of death from infec-
tious disease worldwide with 80,000 pediatric deaths annually [1].
Commonly children develop tuberculosis after contact with an
infected adult. Disease caused byMycobacterium tuberculosis (Mtb)
is usually asymptomatic in pediatric patients and resolves after
completion of standard therapy [2e4]. Rare reports document
children greater than 10 years of age in endemic regions developing
adult type cavitary disease, an infectious pulmonary tuberculosis
lesion [5]. With increasing immigration of refugees from endemic
regions into the United States, the Center for Disease Control
implemented standardized testing and treatment of TB. However
evenwith identiﬁcation of disease, many immigrants may not seekium tuberculosis; INH, Isoni-
uberculosis; IGRA, Interferon
y Center, Department of Pe-
onal Building, 215, W Bowery
Ltd. This is an open access article utreatment or complete therapy given lack of health insurance, and
poor access to health care. The following case is an immigrant
adolescent that completed therapy with Isoniazid (INH) for latent
tuberculosis (LTBI) and developed a rare infectious post primary
tuberculosis cavitary pulmonary lesion.2. Case report
A Nepalese 14 year old adolescent female with history of treated
LTBI presented to the emergency department (ED) with two weeks
of non-productive cough and acute fever. The patient emigrated
from southern Nepal two years prior with PPD induration of 11mm,
positive Interferon gamma release assay (IGRA) (Quantiferon-TB
Gold in-tube test) of 9.55 IU/ml and negative chest radiograph. The
patient completed a ten month course of INH and was asymp-
tomatic until the start of this acute episode. Chart review docu-
ments patient reported compliance with INH during a TB follow-up
visit, but there is no mention of directly observed therapy (DOT) or
involvement of the local health department. She had no evidence of
immunosuppression though was noted to have low vitamin D
levels and growth along the ﬁfth percentile. In the ED she was
afebrile, tachycardiac, and tachypneic; she received ﬂuidnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-ray revealing ovoid lucency in left upper zone consistent with cavitary
lesion.
Fig. 3. Chest X-ray demonstrating nearly complete resolution of previously noted air
space disease in left upper zone.
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negative blood culture. Chest X-ray demonstrated an ovoid lucency
in left upper lobe measuring 1.6 cm by 1.7 cm concerning for post-
infectious pneumatocele versus cavitary necrosis in a consolidation
(Fig. 1). She received IV ceftriaxone and was admitted to the pedi-
atric infectious disease service.
After further review, she was placed in airborne isolation with
concern for TB. Physical exam noted a thin, well-appearing teen
with decreased air exchange in the upper left lung ﬁeld. Chest CT
revealed a 2.4 cm cavitary lesion in the left upper lobe consistent
with post-primary TB (Fig. 2). Repeat IGRA was positive. Sample
was obtained from three consecutive daily gastric aspirates which
grew Mtb pan-sensitive to Ethambutol, INH, Pyrazinamide, and
Rifampin. Four drug therapy was initiated under direct observation
of the health department and she was followed by the local pedi-
atric infectious disease specialist. Repeat sputum acid fast smears
were negative for mycobacterium and chest X-ray showed signiﬁ-
cant improvement upon completion of therapy (Fig. 3).3. Discussion
Cavitary pulmonary TB is rarely seen in the pediatric population,
even in countries with a high prevalence of TB. A study of 27
children with cavitary TB in India revealed it was more common inFig. 2. Chest CT conﬁrming cavitary lesion in left uppefemale children secondary to poor nutrition and irregular drug
therapy, children age 7e12 related to increased frequency of post
primary disease during puberty and in those with contact with an
adult with TB [6]. A South African report documents eight children
ages 10e14, with sputum smear-positive disease with adult type
cavitation on chest X-ray [5]. Our patient was less than the ﬁfth
percentile for height and weight, was pubertal, was not immuno-
compromised, resided with family members who emigrated from
Nepal (including a sister treated for LTBI), had cavitary lesions on
chest CT and sputum-smear positive disease all while residing in a
developed country. This is a notable case of pan-sensitive sputum
positive post-infectious pulmonary TB disease with adult type
cavitation in an adolescent, which developed after completing
standard therapy with INH.
This case raises multiple questions regarding pediatric TB and
necessitates discussion for directly observed drug therapy. The
patient above reported compliance with INH therapy despite
lacking documentation of DOT or involvement of the health
department. Does DOT and involvement of the health department
make a difference in patient compliance? Or is routine follow-upr lobe consistent with post primary tuberculosis.
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show greater treatment compliance, as high as 90%, with a patient
centered approach using DOT [4]. In our case the patient was dis-
charged from the hospital with DOT by the local health department
who documented subsequent sputum cultures were negative after
treatment. Follow-up with infectious disease specialist documents
patient compliance, monitored drug side effects and demonstrated
nearly complete resolution of cavitary lesion on repeat chest X-ray.
Clearly involvement of the local health department and infectious
disease experts provides reassuring evidence and a greater level of
conﬁdence for disease clearance.
If the patient in the above case was compliant with INH therapy
and proceeded to develop post-primary cavitary TB, physicians
must reconsider the rarity of INH resistant TB in the pediatric
population. Isoniazid is extremely effective in the treatment of LTBI
and use is implicated to help prevent reactivation of pulmonary
disease [7]. With excellent adherence to medication, INH therapy of
LTBI is close to 100% effective to prevent future disease [8,9]. In such
a case, onemust question if this patient developed an INH-resistant
strain of Mtb (which is unlikely since sputum cultures were sensi-
tive to INH), or if the patient was truly compliant with INH therapy.
With more patients emigrating from countries with high prev-
alence of TB, there is likelihood of increasing number of pediatric
cases of infectious TB in the developed countries. Pediatricians
must be concerned for TB in a patient presenting with prolonged
cough, fever, and constitutional symptoms e with heightened
awareness in foreign born populations. Pediatricians must espe-
cially recognize radiologic ﬁndings concerning for TB including
cavitary lesions and lymphadenopathy. If there is concern for TB,
appropriate isolation protocol must be put into action immediately
to prevent undue transmission of disease. Physicians must recog-
nize the impact on public health and the potential for spread of
active TB within schools and the community especially in pulmo-
nary cavitary lesion.Funding source
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